DESIRAE SEGURA: Open Payments
NPI 1477153278 · HAWTHORNE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 67 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $157 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $440 |
| Antares Pharma, Inc. | 8 | $138 |
| Novo Nordisk Inc | 5 | $116 |
| Dexcom, Inc. | 4 | $95 |
| Lilly USA, LLC | 8 | $92 |
| Verity Pharmaceuticals Inc. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| GlaxoSmithKline, LLC. | 2 | $54 |
Products named: AIRSUPRA, XYOSTED, BREZTRI, Dexcom G6 Transmitter, Tlando, JARDIANCE, Kerendia, OTEZLA.
Industry payments across CA — which companies pay providers there.
